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Managing mental health co-morbidities in hepatitis C: a systematic 
review of clinical guidelines
ABSTRACT
BACKGROUND:
Mental health co-morbidities are prevalent in 
hepatitis C (HCV), and in practice often 
considered a contraindication for initiation of 
treatment. A systematic review was conducted 
to explore whether and how current HCV 
clinical practice guidelines address pre-
existing mental health co-morbidities.
METHODS: 
A review of the literature was undertaken to 
identify guidelines for the management of 
HCV, published in English, between 2002 and 
January 2015. Characteristics of the 
guidelines were recorded and key themes on 
mental health were summarized across 
predefined stages in the patient journey 
(diagnosis, pre-HCV drug therapy, on HCV 
drug therapy, post-HCV drug therapy, 
advanced disease or palliative care).
RESULTS:
Twenty-five HCV clinical guidelines were 
included. Referral to psychiatrist is generally 
recommended as pre- and in-treatment 
assessment of mental health co-morbidities 
but HCV guidelines do not offer explicit 
instructions on how to manage mental health 
co-morbidities. Post-treatment assessment of 
mental health co-morbidities were lacking.
CONCLUSIONS:
Current chronic HCV clinical guidelines are 
limited in their advice to clinicians regarding 
the management of mental health co-
morbidities.
KEY MESSAGE:
There is an immediate need for clear and 
accessible clinical guidelines to better support 
patients with HCV and mental health co-
morbidities to successfully initiate and 
complete antiviral treatment programs.
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Methods
Databases:
• MEDLINE (PubMed), 
• Embase,
• TRIP databases, 
• National Guideline Clearinghouse,
• National Health and Medical Research Council 
(NHMRC) Clinical Practice Guidelines Portal, 
• Australasian Society of HIV Medicine, 
Guidelines International Network,
• California Department of Public Health, 
• Canadian Medical Association,
• National Institute for Health and Care 
Excellence (NICE), and 
• Ministry of Health Singapore.
MeSH terms:
• practice guideline, and
• hepatitis C.
Inclusion Criteria:
• Institute of Medicine’s definition of a ‘clinical 
practice guideline’:
statements that include recommendations 
intended to optimize patient care that are 
informed by a systematic review of evidence 
and an assessment of the benefits and harms of 
alternative care options.
– Based on a systematic literature review, 
– Made by a panel of experts, or 
– provided a level of evidence for their 
recommendations. 
• Full text available in English.
Exclusion Criteria:
• HIV co-infection, 
• targeted treatment (e.g. ‘boceprevir’ and 
‘telaprevir’), 
• one genotype, 
• advanced liver disease, 
• post transplantation, or 
• management of infected health care workers or 
occupational exposure. 
Guideline Selection:
Three authors [TB, LD, DL] reviewed title and 
abstracts of guidelines independently for 
relevance and full texts of all guidelines 
considered relevant were reviewed to determine if 
they met eligibility criteria.
Results
Target Audience:
• Two guidelines on general practitioners, 
• one guideline on nurses, 
• one guideline on specialists,
• Nine guidelines did not clearly specify a target 
audience, 
• One guideline was intended for policymakers, 
government officials, and others working in 
low- and middle-income countries. 
Key Findings:
• Patients with mental health problems and HCV 
are eligible for treatment, 
• however, 11 out of 25 guidelines formulated 
that major mental health problems were 
considered a contra-indication. 
• The descriptions of mental health contra-
indications for treatment varied considerably 
(e.g. psychiatric disorders, severe mental 
illness, severe depression).
• Eight guidelines did not mention the need for 
mental health assessment or intervention, eight 
discussed mental health to some degree but did 
not proved recommendations, two provided 
recommendations, and seven provided evidence 
based recommendations on the management of 
mental health.
Discussion
• Mental health is an important issue at all 
stages of disease when treating patients with 
HCV. 
• Nonetheless, clinical practice guidelines 
provide insufficient guidance for the 
management of mental health problems.
• Of the 25 guidelines we identified, only 
seven provided evidence based 
recommendations on the management of 
mental health problems.
• The recommendations at time of diagnosis 
were confined to referral to a psychiatrist or 
monitoring, with limited guidance on how to 
monitor or manage mental health problems. 
• Evidence suggests a range of tools and 
strategies have been published in mental 
health literature to support assessment, 
monitoring and management, however few 
have been incorporated into current HCV 
clinical guidelines.
• A recurrent theme across the guidelines was 
the need for multidisciplinary care. The 
majority of guidelines recommended that 
optimal management of hepatitis C requires a 
multidisciplinary approach. However, what 
that type of care comprises and how it should 
be organized is not described. 
• Another theme that regularly reappeared in 
the context multidisciplinary teams and 
mental health was adherence to therapy. 
Patients with comorbid medical and 
psychiatric conditions may be less likely to 
adhere to antiviral therapy, which may lead 
to poorer outcomes. Again, no clear guidance 
was formulated.
• Future research is required to examine what 
comprises best practice in HCV and mental 
health management including criteria to 
indicate the optimal time to initiate anti-
depressant treatment, the type of anti-
depressants, increased clarity of the language 
and terms used in the clinical guidelines, and 
new models of care that address the needs of 
the population groups. 
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